Zyprexa Growth Strategy Includes Discussing Weight Gain With Doctors
This article was originally published in The Pink Sheet Daily
Executive Summary
Marketing efforts include helping physicians manage weight gain associated with use of the antipsychotic and identify "appropriate" patients for Zyprexa therapy. Lilly estimates 30% of patients will gain "a lot of weight" while taking olanzapine.
You may also be interested in...
"Black Box" Will Not Deter Off-Label Zyprexa Use In Dementia Patients, Lilly Says
The company points to the lack of indicated alternatives for treating dementia-related psychosis as one reason why psychiatrists will continue to prescribe atypical antipsychotics despite a new "black box" warning on mortality in that patient population. First quarter U.S. Zyprexa sales fell 17% compared to the same period in 2004.
"Black Box" Will Not Deter Off-Label Zyprexa Use In Dementia Patients, Lilly Says
The company points to the lack of indicated alternatives for treating dementia-related psychosis as one reason why psychiatrists will continue to prescribe atypical antipsychotics despite a new "black box" warning on mortality in that patient population. First quarter U.S. Zyprexa sales fell 17% compared to the same period in 2004.
Zyprexa Follow-On Drugs Will Not Have Same Side Effect Profile As Atypicals, Lilly Says
Zyprexa follow-on products will not be associated with the same adverse effects as the atypical antipsychotics, Lilly maintains during Bear Stearns health care conference in New York Sept. 14